1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: agricultural
Phyto Chem (India) Ltd.

Phyto Chem (India) Ltd.

BBSE:PHYTO
16.70
INR
-0.20
(-1.18%)
-5.17EPS
101.05MMarket Cap
Phyto Chem (India) Ltd.
BSE:PHYTO
(Bombay Stock Exchange)

Recent

price

16.70

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
70.54
62.63
76.63
71.95
100.22
53.52
109.16
137.43
137.45
102.84
103.46
53.76
62.23
34.44
32.74
21.09
17.66
Revenue per Share
1.35
2.2
1.49
1.43
1.25
0.27
1.97
2.14
1.69
1.04
1.15
0.53
0.52
-7.75
-2.31
-4.19
-5.17
Basic EPS, GAAP
-5.01
-5.51
-6.88
-5.67
-5.04
-1.25
3.42
-1.25
4.48
2.4
-2.09
7.67
3.29
7.15
4.11
2.08
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
14.46
16.66
16.99
17.25
18.1
17.9
19.31
20.5
21.91
22.9
23.68
24.31
24.68
17.11
14.85
10.63
- -
Book Value per Share
14.46
16.66
16.99
17.25
18.1
17.9
19.31
20.5
21.91
22.9
23.68
24.31
24.68
17.11
14.85
10.63
- -
Tangible Book Value per Share
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
Basic Weighted Avg Shares
303
269
330
309
431
230
469
591
591
442
445
231
268
148
141
91
76
Sales/Revenue/Turnover
8.79
8.74
7.51
8.45
5.4
6.68
5.86
4.35
4.77
5.32
4.67
5.75
9.25
-23.96
-10.32
-23.49
-29.15
Operating Margin (%)
2
2
3
4
6
3
3
4
4
4
4
4
4
3
3
3
3
Depreciation Expense
6
9
6
6
5
1
8
9
7
4
5
2
2
-33
-10
-18
-22
Net Income, GAAP
34.56
37.73
33.52
33.84
33.36
36.5
27.24
24.01
19.62
- -
- -
- -
15.85
- -
- -
- -
- -
Effective Tax Rate (%)
1.91
3.52
1.94
1.99
1.24
0.51
1.8
1.55
1.23
1.01
1.11
0.99
0.83
-22.49
-7.04
-19.88
-29.28
Profit Margin (%)
65
69
57
52
59
61
67
72
75
86
105
100
111
67
51
24
- -
Working Capital
27
31
23
20
16
17
15
27
25
31
36
24
28
17
11
1
- -
LT Debt
62
72
73
74
78
77
83
88
94
98
102
105
106
74
64
46
- -
Total Equity
4.72
6.08
3.59
3.01
2.4
0.44
7.89
4.79
7.46
- -
- -
- -
6.55
- -
- -
- -
- -
Return on Invested Capital (%)
4.72
6.08
3.5
8.28
6.81
4.81
7.95
8.61
7.57
- -
- -
- -
6.42
- -
- -
- -
- -
Return on Capital (%)
9.8
14.15
8.83
8.35
7.06
1.5
10.57
10.73
7.97
4.63
4.92
2.23
2.11
-37.06
-14.42
-32.91
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
204
- -
LT Borrowings
- -
1
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
4
Market Capitalization
122
93
101

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
251
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
164
- -
Inventories
- -
83
- -
Total Current Liabilities
- -
228
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
204
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-3.93%
-13.63%
-28.46%
Free Cash Flow
-170.13%
-99.8%
-49.43%
Net Income, GAAP
-105.64%
-328.52%
81.83%
Sales/Revenue/Turnover
-1.22%
-23.49%
-35.57%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
46
44
36
15
141
2026
15
44
30
2
91
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-3.41
0.26
3.54
-2.69
-2.31
2026
-1.13
-1.3
-1.13
-0.64
-4.19
2027
-2.1
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Similar Companies
UPL Limited (NSE:UPL)
Mosaic Company (The) (NYSE:MOS)
CF Industries Holdings, Inc. (NYSE:CF)
PhosAgro (MOEX:PHOR)
Abou Kir Fertilizers & Chemical Industries Co. (EGX:ABUK)
Misr Fertilizers Production Company MOPCO (EGX:MFPC)
Business
Phyto Chem (India) Limited is a pharmaceutical company engaged primarily in the manufacturing, marketing, and export of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. Its core product portfolio includes a wide range of APIs such as antibiotics, antifungals, anti-infectives, and other therapeutic segments. The company also develops and supplies formulations and specialty chemicals to domestic and international markets. Operating mainly in India, it serves pharmaceutical companies globally with a diversified product range tailored for several therapeutic applications. Founded in 1979 and headquartered in Mumbai, Maharashtra, Phyto Chem India Limited has established a strong presence in the pharmaceutical sector, supporting a broad spectrum of global pharmaceutical clients. The company focuses on research and development to enhance its product offerings and comply with international regulatory standards. In the last two years, Phyto Chem has expanded its strategic alliances and enhanced its manufacturing capabilities to boost exports and product development. The company has undertaken operational improvements and capacity expansions to meet increasing demand in regulated markets. It continues to invest in innovation and regulatory compliance, strengthening its position in the pharmaceutical ingredients supply chain while maintaining a focus on quality and sustainability. Phyto Chem’s business segments include pharmaceutical APIs, intermediates, custom synthesis services, and specialty chemical products. Its market extends beyond India to various countries worldwide, emphasizing export of high-quality pharmaceutical ingredients. The company remains privately held with no recent name changes or major reorganizations reported. This comprehensive scope of manufacturing, research, and export positions Phyto Chem (India) Limited as a notable participant in the pharmaceutical ingredient supply domain with an ongoing commitment to growth and innovation.